A series of bishydrazide compounds have been developed for selective turn-on detection of Al3+ cation, based on metal chelation-enhanced fluorescence (CHEF) effects that inhibit the nonradiative PET and ESIPT processes. In aqueous solution, Al3+ selectively induces strong fluorescence of these compounds with large Stokes shifts up to ∼133 nm and emission colors varying from blue to orange. In the solid phase, both Al3+ and Zn2+ give apparent fluorescence which is simultaneously detected based on chromatographic separation.

ALP can be used to discriminate between PSC patients with a good and a poor prognosis. These findings indicate that ALP can serve as stratifier, and potentially as surrogate endpoint for clinical trials in PSC.

No abstract